Novee Launches Agentic Fix to Turn Validated Exploits into Implemented Fixes
The AI Search Shift: A Survival Guide for CMOs, PR Professionals, and Website Managers
An Architectural Approach to Solving Prompt Security Challenges
Optical Networking At Micro Scale
TRUEiGTECH Launches TruePredict to Power FIFA World Cup Sports Prediction Platforms for iGaming Operators
PALO ALTO, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”),…
Announces Awarding of Inducement Grant to New Chief Medical Officer Carlsbad, CA, Sept. 11, 2023 (GLOBE…
Announces Awarding of Inducement Grant to New Chief Medical Officer Carlsbad, CA, Sept. 11, 2023 (GLOBE…
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 11, 2023 (GLOBE NEWSWIRE) — Centogene N.V….
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 11, 2023 (GLOBE NEWSWIRE) — Centogene N.V….
Overall response rate (ORR) greater than 50% across three assessment criteria Median duration of tovorafenib…
Overall response rate (ORR) greater than 50% across three assessment criteria Median duration of tovorafenib…
Trial to Assess Multi Cancer Genetic Risk Assessment in General Practice MELBOURNE, Australia, Sept. 11,…
Trial to Assess Multi Cancer Genetic Risk Assessment in General Practice MELBOURNE, Australia, Sept. 11,…
Evaxion is the first organization to validate an AI model that outcompetes state-of-the-art vaccine development…
Evaxion is the first organization to validate an AI model that outcompetes state-of-the-art vaccine development…
SAN DIEGO, Sept. 11, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
SAN DIEGO, Sept. 11, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
MBX 2109 was observed to be generally well-tolerated MBX 2109 increased albumin adjusted serum calcium…
MBX 2109 was observed to be generally well-tolerated MBX 2109 increased albumin adjusted serum calcium…
Post-hoc analysis from Phase 1b/2a study in pulmonary sarcoidosis presented at the European Respiratory Society…
Post-hoc analysis from Phase 1b/2a study in pulmonary sarcoidosis presented at the European Respiratory Society…
Company to present BDTX-1535 dose escalation data in NSCLC at the AACR-NCI-EORTC Conference in October…
Company to present BDTX-1535 dose escalation data in NSCLC at the AACR-NCI-EORTC Conference in October…
Proof-of-concept manufacturing to be provided by Cellares for a key Lyell CAR T-cell therapy using…